In addition, a small pilot safety study published in Alternative Therapies in Health and Medicine showed that intravenous infusions of BPC-157 up to 20 milligrams were well-tolerated with no reported adverse effects in healthy adults, providing initial evidence that the peptide can be administered safely, a necessary step before larger efficacy trials on healing outcomes are conducted
At GCGR, the potency is similarly high, providing the balanced triple-agonist profile that distinguishes retatrutide from the imbalanced dual-agonist tirzepatide and from selective GLP-1R agonists like semaglutide
Lind H, Gameiro SR, Jochems C, Donahue RN, Strauss J, Gulley JM, et al
GHK-Cu fits into that picture naturally because it addresses the same biological process from a different angle, restoring the signal instead of forcing the response through physical injury
Guo C, Wen J, Sun Y, Liang G, Wang Z, Pan L, Huang J, Liao Y, Wang Z, Chen Q et al (2024a) Pyrroloquinoline quinone production defines the ability of Devosia species to degrade deoxynivalenol